Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody

Catalog No. ABIN7538071

This anti-FOLR1 (Mirvetuximab Biosimilar) antibody is a Human Chimeric antibody detecting FOLR1 (Mirvetuximab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody (ABIN7538071)

Target: FOLR1 (Mirvetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Chimeric

Conjugate: This FOLR1 (Mirvetuximab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-FOLR1 (Mirvetuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Mirvetuximab Biosimilar - Anti-FOLR1 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for FOLR1 (Mirvetuximab Biosimilar)

Target: FOLR1 (Mirvetuximab Biosimilar)

Target Type: Biosimilar

Background: Mirvetuximab is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.

CAS-No: 1453084-36-0